MALE INFERTILITY THERAPY: ANALYSIS OF STUDIES
Keywords:
Keywords: male infertility, idiopathic infertility, pathozoospermia, antioxidant therapy, AndroDozAbstract
Аnnotation. AndroDoz has shown promising clinical efficacy in the
treatment of male infertility. Its antioxidant components have been associated with
improved semen quality, including increased sperm concentration, motility, and
normal morphology. Clinical studies also report reduced sperm DNA
fragmentation and higher pregnancy rates, both via assisted reproductive
technologies and natural conception. The absence of adverse effects supports its
safety and potential for widespread use in patients with pathozoospermia and
idiopathic infertility.
References
1. Agarwal A., Mulgund A., Hamada A., Chyatte M.R. A unique view on
male infertility around the globe. Reprod Biol Endocrinol. 2015;13:37. doi:
10.1186/s12958-015-0032-1.
2. Agarwal A., Mulgund A., Hamada A., Chyatte M.R. A unique view on
male infertility around the globe. Reproductive Biology and Endocrinology.
2015;(13):37. Available at: https:// rbej.biomedcentral.com/articles/10.1186/
s12958-015-0032-1.
3. Levine H., Jørgensen N., Martino-Andrade A., Mendiola J., Weksler-Derri
D., Mindlis I., Pinotti R., Swan S.H. Temporal trends in sperm count: a systematic
review and meta-regression analysis. Hum Reprod Update. 2017;23(6):646-659.
doi: 10.1093/humupd/dmx022.
4. Nieschlag E., Behre H.M., Nieschlag S. (Ed.). Andrology: Male
Reproductive Health and Disfunction. 3rd. 2010;(629). doi: 10.1007/978- 3-540-
78355-8.
5. Punab M., Poolamets O., Paju P., Vihljajev V., Pomm K., Ladva
R., Korrovits P., Laan M. Causes of male infertility: a 9-year prospective
monocentre study on 1737 patients with reduced total sperm counts. Hum Reprod.
2017;32(1):18-31. doi: 10.1093/humrep/ dew284.
6. Kamkar N., Ramezanali F., Sabbaghian M. The relationship between
sperm DNA fragmentation, free radicals and antioxidant capacity with idiopathic
repeated pregnancy loss. Reprod Biol. 2018;18(4):330-335. doi: 10.1016/j.
repbio.2018.11.002.
